Clinical Trial Update: VELCADE/Melphalan/Prednisone Versus Melphalan/Prednisone in Patients With Previously Untreated Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Velcade/Melphalan/Prednisone versus Melphalan/Prednisone in newly diagnosed multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Melphalan (Melphalan)
• PREDNISONE (Prednisone)
• Velcade (bortezomib)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED